Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Breast neoplasms malignant and unspecified (incl nipple)
ADR ID BADD_A00696
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
Description Not Available
MedDRA Code 10006291
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02043Sodium iodide i-131--
BADD_D02047Sodium oxybate0.000536%
BADD_D02066Spironolactone--
BADD_D02093Sulfasalazine0.000606%
BADD_D02098Sumatriptan--
BADD_D02099Sumatriptan succinate--
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02111Tamoxifen0.000238%
BADD_D02112Tamoxifen citrate--
BADD_D02139Tegaserod maleate--
BADD_D02140Tegaserode--
BADD_D02165Teriflunomide0.009403%
BADD_D02170Testosterone0.000364%
BADD_D02174Testosterone undecanoate-
BADD_D02236Tofacitinib0.005063%
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan--
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02259Trandolapril--
BADD_D02299Trisequens--
BADD_D02312Ulipristal--
BADD_D02321Ursodiol--
BADD_D02322Ustekinumab--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000899%
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.000112%
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages